证券之星消息，东阿阿胶(000423)12月11日在投资者关系平台上答复投资者关心的问题。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 投资者提问：请问公司高比例分红回馈股东是否写入制度规范。谢谢 东阿阿胶回复：您好！感谢您对公司的关注。公司始终高度重视股东回报，并保持相对稳定且积极的分 红政策。未来，公司将在综合考虑自身经营发展规划、盈利水平、现金流状况以及股东利益等多方面因 素的基础上，有序推进分红政策进一步制度化，以增强回报的稳定性和可预期性。谢谢！ ...

Overview - The aging population in China is driving the rapid rise of the "silver economy," with a strong demand for easy-to-swallow, low-sugar ready-to-eat health products among the elderly, creating a stable consumer group [1] - The health awareness of the general public is increasing, leading to a shift in health maintenance from being exclusive to the elderly to being integrated into the daily lives of younger generations, who are adopting a "light nourishment" concept [1][11] - The ready-to-eat health product market in China is projected to reach a market size of 217.1 billion yuan in 2024, with a year-on-year growth of 10.5% [1][11] Market Characteristics - Common ready-to-eat health products include ready-to-eat donkey-hide gelatin, fresh stewed bird's nest, ready-to-eat ginseng, and others, each targeting different consumer demographics [3][4] - The consumer base for these products has expanded beyond the elderly to include young professionals and health-conscious individuals [7] Development History - Prior to 2000, the market primarily consisted of traditional health ingredients, with the introduction of initial ready-to-eat products occurring in response to consumer demand for convenience [3] - The concept of ready-to-eat health products has evolved significantly since 2016, expanding to include a variety of products that emphasize freshness and natural ingredients [3][4] Market Policies - Recent policies in China emphasize food safety and quality control, requiring strict compliance from ready-to-eat health product manufacturers, thereby promoting industry standardization and high-quality development [6][7] Industry Chain - The industry chain includes suppliers of raw materials, production, and packaging, with a growing focus on meeting the needs of younger consumers and adapting marketing strategies accordingly [7][9] Sales Channels - The online sales channel for ready-to-eat health products is expected to account for 52.8% of the market by 2024, surpassing traditional offline channels [9][10] Competitive Landscape - The market exhibits a varied competitive landscape, with certain segments like ready-to-eat donkey-hide gelatin and fresh stewed bird's nest showing oligopolistic characteristics, while other segments remain fragmented with opportunities for smaller brands [12][13] Future Trends - The industry is expected to continue evolving towards snack-like, convenient forms, with an emphasis on innovative combinations of ingredients to meet specific health needs [14]

Core Insights - The rise of the "warm economy" during winter has led to increased consumer demand for health and wellness products, particularly among younger demographics who prefer convenient and innovative options [1][3][17] - Traditional brands like Dong'e Ejiao are adapting to these trends by launching new product lines that appeal to younger consumers, such as instant Ejiao powder and health snacks [2][8] - New brands like Zhenbu'er are leveraging e-commerce platforms like Douyin to introduce unique products, including the "waterless foot soak" heated boots, catering to fragmented wellness routines [4][5][17] Product Innovation - Dong'e Ejiao has diversified its product offerings beyond traditional forms to include Ejiao dates and cakes, responding to the growing health consciousness among consumers [2][8] - Zhenbu'er has introduced innovative products like the Oolong tea-scented heated neck pillow and the "waterless foot soak" boots, which have gained popularity on Douyin [4][5][17] - Both brands are focusing on creating products that are easy to use and suitable for various consumption scenarios, such as at work or during travel [14][17] E-commerce Strategy - Dong'e Ejiao has successfully expanded its online presence, achieving significant sales through its flagship store on Douyin, with over 440,000 orders recorded [7][8] - Zhenbu'er has also seen impressive sales, with a total exceeding 2.6 million orders across its stores on Douyin [7][8] - The content-driven approach of Douyin e-commerce allows brands to engage consumers effectively, with a focus on storytelling and cultural heritage [9][12][17] Market Trends - The shift towards lighter, more convenient health products reflects changing consumer preferences, particularly among younger generations [14][17] - Both Dong'e Ejiao and Zhenbu'er are targeting the 18-24 age group, with a focus on urban youth and small-town consumers [14][17] - The collaboration between brands and Douyin is fostering a "dual growth" model, where both parties benefit from shared insights and innovations [17]

Core Viewpoint - Dong-E E-Jiao announced a share buyback plan for the first time since its listing in 1996, with a total amount between 100 million and 200 million yuan, aimed at enhancing investor confidence and recognizing the company's intrinsic value [1][2]. Financial Performance - As of September 30, 2025, Dong-E E-Jiao reported total assets of 12.75 billion yuan and equity attributable to shareholders of 9.948 billion yuan, with a liquidity ratio of 9.823 billion yuan [3]. - The planned buyback amount represents only 1.57% of total assets, 2.01% of equity, and 2.04% of current assets [3]. - The company has maintained a high cash dividend policy since its listing, with cumulative dividends reaching 10.03 billion yuan and a consistent payout ratio of nearly 100% in recent years [3]. Revenue and Profit Growth - From 2020 to 2024, Dong-E E-Jiao's revenue grew from 3.409 billion yuan to 5.921 billion yuan, with a compound annual growth rate (CAGR) of 14.7%, while net profit increased from 43 million yuan to 1.557 billion yuan, achieving a CAGR of 187.3% [5]. - For the first three quarters of 2025, the company reported revenue of 4.766 billion yuan and a net profit of 1.274 billion yuan, with a gross margin increase of 3.33 percentage points to 73.69% [5][6]. Research and Development - Dong-E E-Jiao invested 145 million yuan in R&D for the first three quarters of 2025, marking a 62.29% year-on-year increase, with total R&D expenses over the past three years amounting to 492 million yuan [1][6]. - The company has achieved significant R&D milestones, including the development of rapid preparation techniques for traditional products and recognition for its innovative treatments [6]. Strategic Partnerships - Dong-E E-Jiao is collaborating with China Resources Group to explore international markets and invest in a 1 billion yuan pharmaceutical industry fund, focusing on traditional Chinese medicine and synthetic biology [7].

Group 1 - The core viewpoint of the article highlights the technological advancements and digital transformation in Dong'e Ejiao's production processes, showcasing the integration of smart manufacturing and data analytics in traditional industries [1][2] - Dong'e Ejiao has achieved a maximum daily production capacity of 1.5 million bottles through an automated production line, which has improved efficiency by 60% and enhanced the cleanliness and organization of the workspace [1] - The company has implemented smart management in the upstream donkey breeding segment, utilizing intelligent ear tags for real-time monitoring of health data, thereby enhancing the overall efficiency of the supply chain [1] Group 2 - Dong'e County is focusing on nurturing high-quality enterprises, establishing a cultivation database for small and medium-sized enterprises based on their scale, innovation capability, and market competitiveness [2] - In 2023, Dong'e County has organized 30 enterprises to apply for high-tech enterprise status, with Dong'e Ejiao being recognized as one of the first batch of exemplary intelligent factories in China [2] - The high-tech industry in Dong'e County has seen a growth rate of 13.85% from January to October, with its output value accounting for 72.09% of the total industrial output [2] Group 3 - There is an ongoing effort to strengthen university-industry collaboration, with 26 agreements signed between local universities and enterprises, including partnerships with renowned academic teams [3] - The establishment of the Liaocheng University Dong'e Industry Technology Research Institute and recognition of Aorun Pharmaceutical as a provincial postdoctoral innovation practice base indicate a commitment to fostering innovation and talent development [3] - The integration of talent cultivation with industry needs is being emphasized, with the addition of a new Taishan industry leader and a project selected for a national talent program [3]

编辑 杨娟娟 新京报贝壳财经讯 12月4日，东阿阿胶发布公告称，基于对未来发展的信心和对公司内在价值的认可， 为维护广大投资者利益、增强投资者信心，进一步提升公司价值，在考虑经营情况和财务状况的基础 上，公司拟以自有资金通过二级市场回购公司股份，拟回购金额不超过2亿元（含），不低于1亿元 （含）。本次回购股份将用于注销并减少公司注册资本。 ...

Group 1 - Meilixin plans to raise no more than 1.2 billion yuan for semiconductor equipment precision components, communication and automotive parts projects, and to supplement working capital [2] - Olin Bio has prepaid corporate income tax totaling 4.2001 million yuan, with no penalties from tax authorities [3] - Haisen Pharmaceutical's directors and executives plan to reduce their holdings by no more than 124,300 shares, accounting for 0.0816% of the total share capital [4] Group 2 - Aibulu intends to sell 47.4% and 31.6% stakes in its subsidiary Jinque Agriculture for a total of 12.3914 million yuan [5] - Chaoying Electronics plans to increase its Thai subsidiary's capital by 100 million USD for AI high-end PCB expansion [6] - Bona Film Group states that the box office revenue for "Avatar 3" is difficult to predict and the investment return rights are low [7] Group 3 - Junya Technology's PCB products for humanoid robots contribute less than 0.05% to its revenue [9] - Aerospace Electromechanical confirms that its main business does not involve commercial aerospace [10] - Deyi Culture's major shareholder plans to reduce holdings by no more than 2% of shares [11] Group 4 - China National Materials International signed a 2.7 billion yuan engineering contract for a molybdenum mining project [12] - Weiguang Bio plans to sign a 1.13 billion yuan technology cooperation contract for blood products [13] - Suhao Huihong intends to swap assets with its controlling shareholder for a 2.33% stake in Zijin Property Insurance [14] Group 5 - Haike Xinyuan's employee strategic placement plan intends to reduce holdings by no more than 2.5% of shares [15][16] - Taihao Technology's vice president resigns for personal reasons [17] - Huazhu Gaoke plans to establish a joint venture for 3D printing services with a total investment of 100 million yuan [18] Group 6 - Hubei Energy's November power generation was 2.617 billion kWh, a decrease of 17.94% year-on-year [19] - Dong'a Ejiao plans to repurchase shares worth 100 million to 200 million yuan for capital reduction [20] - Longjiang Transportation's shareholder reduced holdings by 1.2% [21] Group 7 - Feilu Co. plans to reduce holdings by no more than 1.02% of shares [22] - Zhongwei Electronics is planning a change in control, leading to a temporary stock suspension [23] - Zhongheng Group's subsidiary received approval for clinical trials of a new cancer drug [24] Group 8 - Guanzhong Ecology's controlling shareholder changed to Deep Blue Financial Whale [25] - Shennong Seed Industry is transferring a 3.8% stake in a subsidiary for 31.9827 million yuan [26] - Sun Cable's major shareholder plans to reduce holdings by no more than 3% of shares [27] Group 9 - Aiwei Electronics' application for issuing convertible bonds has been approved by the Shanghai Stock Exchange [28] - Chongqing Water intends to acquire wastewater treatment projects for 255 million yuan [29] - Boyun New Materials plans to increase its subsidiary's capital by 285 million yuan through debt-to-equity conversion [30] Group 10 - Zhongbai Group is closing unprofitable stores, expecting a loss of approximately 180 million yuan [31] - Changyuan Power's November power generation decreased by 17.88% year-on-year [32]

Key Points - Junya Technology's PCB products can be used in humanoid robots, but these products account for a very small proportion of the company's revenue [1] - Aerospace Machinery's main business does not involve commercial aerospace [1] - Xinhua Co. plans to invest 153 million yuan in the second phase of its synthetic flavor product base [1] - China National Petroleum plans to acquire 100% equity of three gas storage companies for 40 billion yuan [1] - Dong'e Ejiao intends to repurchase shares worth 100 million to 200 million yuan [1] - Haike New Source Asset Management plans to reduce its holdings by no more than 2.5% [2] - Meilixin plans to raise no more than 1.2 billion yuan for the construction of precision structural components for semiconductor equipment [2] - Huazhong Xinchuang received project designation notification from Beiqi Foton [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000423 证券简称：东阿阿胶 公告编号：2025-71 东阿阿胶股份有限公司 第十一届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 1．东阿阿胶股份有限公司（以下简称"公司"）第十一届董事会第十五次会议，根据公司《董事会议事 规则》等相关规定，全体董事同意豁免本次会议通知时间要求,于2025年12月4日以邮件方式发出会议通 知。 2．本次董事会会议，于2025年12月4日以通讯表决方式召开。 3．会议应出席会议董事8人，实际出席会议董事8人。 4．本次董事会会议的召开，符合有关法律、行政法规、部门规章、规范性文件和公司章程等规定。 二、董事会会议审议情况 本次会议审议并通过了以下议案： 1．《关于以集中竞价交易方式回购公司股份方案的议案》 （1）回购股份的目的 基于对未来发展的信心和对公司内在价值的认可，为维护广大投资者利益、增强投资者信心，进一步提 升公司价值，在综合考虑公司经营情况和财务状况的基础上，公司拟以自有资金或自筹资金，通过二级 市 ...

Group 1 - Company Guanzhong Ecological has changed its controlling shareholder to Deep Blue Whale, with the first phase of share transfer completed involving 14.70 million shares at a price of 15 CNY per share, totaling 221 million CNY [2][3] Group 2 - Company Xingfa Group's subsidiary has signed a processing agreement with Qinghai Fudi to produce 80,000 tons per year of lithium iron phosphate, which is expected to enhance the company's market position in the new energy sector [4] Group 3 - Company Meilixin plans to raise up to 1.2 billion CNY through a private placement, with funds allocated for semiconductor equipment projects and working capital [6] Group 4 - Company Dong'e Ejiao intends to repurchase shares worth between 100 million to 200 million CNY, with a maximum repurchase price of 72.08 CNY per share [8] Group 5 - Company Zhongbai Group has closed 30 underperforming stores to optimize its operations, expecting a one-time loss of approximately 180 million CNY from these closures [12] Group 6 - Company Jinxinnong reported sales of 156,800 pigs in November 2025, generating revenue of 115 million CNY, with an average selling price of 12.13 CNY per kilogram for commercial pigs [12] Group 7 - Company Naxinwei is in the process of applying for H-share issuance and listing on the Hong Kong Stock Exchange, with a final share price set at 116 HKD [18]